Biocept Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month highs with Hormuz crossings, Russian sanctions waiver in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- Nvidia wins CPU business from Modal, previously exclusive to AMD and Intel
Biocept (BIOC) Reports Q2 Loss of $0.38/sh
August 12, 2020 4:19 PM EDTBiocept (NASDAQ: BIOC) reported Q2 EPS of ($0.38), versus ($0.05) reported last year. Revenue for the quarter came in at $1.2 million, versus $917.5 thousand reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More


